Massachusetts, USA-based Millipore Corp has announced the availability of high-quality, labeled secondary antibodies used in single- and double-labeling experiments, fluorescence-activated cell sorting (FACS), enzyme-linked immunoadsorbent assay (ELISA), detection assays and Western blotting applications. This series of antibodies is available either unconjugated or conjugated to an enzyme, biotin or fluorophore. All of Millipore's labeled secondary antibodies are manufactured to exacting standards to provide high quality performance.
Millipore says that enzyme-labeled secondary antibodies, including the hyper-HRP labeled antibody, offer unparalleled sensitivity and permeance in immunohistochemistry applications. The enzyme conjugated antibodies, depending on application, may produce either a protein luminescence or color the proteins to be visible on the membrane.
Biotin conjugation provides high levels of signal amplification with minimal cost. Combining biotinylated secondaries with a matching line of conjugated streptavidin partners, signals can be multiplied quickly, enhancing their sensitivity in all applications.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze